Pain genes.
Pain, which afflicts up to 20% of the population at any time, provides both a massive therapeutic challenge and a route to understanding mechanisms in the nervous system. Specialised sensory neurons (nociceptors) signal the existence of tissue damage to the central nervous system (CNS), where pain is represented in a complex matrix involving many CNS structures. Genetic approaches to investigating pain pathways using model organisms have identified the molecular nature of the transducers, regulatory mechanisms involved in changing neuronal activity, as well as the critical role of immune system cells in driving pain pathways. In man, mapping of human pain mutants as well as twin studies and association studies of altered pain behaviour have identified important regulators of the pain system. In turn, new drug targets for chronic pain treatment have been validated in transgenic mouse studies. Thus, genetic studies of pain pathways have complemented the traditional neuroscience approaches of electrophysiology and pharmacology to give us fresh insights into the molecular basis of pain perception.
Foulkes
Tom
T
Department of Stem Cell Biology and Developmental Genetics, National Institute for Medical Research, London, United Kingdom.
Wood
John N
JN
D000344:Afferent Pathways / Q000187:drug effects / Q000502:physiology; D000818:Animals; D005544:Forecasting; D017353:Gene Deletion; D005796:Genes; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D008959:Models, Neurological; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology; D010146:Pain / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D017933:Peripheral Nervous System / Q000187:drug effects / Q000502:physiology; D020161:Physical Chromosome Mapping; D020641:Polymorphism, Single Nucleotide; D018433:Twin Studies as Topic